These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 1831226

  • 1. Induction of opsonic antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide by an anti-idiotypic monoclonal antibody.
    Schreiber JR, Pier GB, Grout M, Nixon K, Patawaran M.
    J Infect Dis; 1991 Sep; 164(3):507-14. PubMed ID: 1831226
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine.
    Theilacker C, Coleman FT, Mueschenborn S, Llosa N, Grout M, Pier GB.
    Infect Immun; 2003 Jul; 71(7):3875-84. PubMed ID: 12819072
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
    Meluleni GJ, Grout M, Evans DJ, Pier GB.
    J Immunol; 1995 Aug 15; 155(4):2029-38. PubMed ID: 7636254
    [Abstract] [Full Text] [Related]

  • 7. Opsonophagocytic killing activity of rabbit antibody to Pseudomonas aeruginosa mucoid exopolysaccharide.
    Ames P, DesJardins D, Pier GB.
    Infect Immun; 1985 Aug 15; 49(2):281-5. PubMed ID: 3160660
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cross-sectional and longitudinal studies of naturally occurring antibodies to Pseudomonas aeruginosa in cystic fibrosis indicate absence of antibody-mediated protection and decline in opsonic quality after infection.
    Tosi MF, Zakem-Cloud H, Demko CA, Schreiber JR, Stern RC, Konstan MW, Berger M.
    J Infect Dis; 1995 Aug 15; 172(2):453-61. PubMed ID: 7622889
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunogenic properties of Pseudomonas aeruginosa mucoid exopolysaccharide.
    Garner CV, DesJardins D, Pier GB.
    Infect Immun; 1990 Jun 15; 58(6):1835-42. PubMed ID: 2140341
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis.
    Pier GB, Saunders JM, Ames P, Edwards MS, Auerbach H, Goldfarb J, Speert DP, Hurwitch S.
    N Engl J Med; 1987 Sep 24; 317(13):793-8. PubMed ID: 2957591
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and characterization of Pseudomonas aeruginosa alginate-tetanus toxoid conjugate.
    Kashef N, Behzadian-Nejad Q, Najar-Peerayeh S, Mousavi-Hosseini K, Moazzeni M, Djavid GE.
    J Med Microbiol; 2006 Oct 24; 55(Pt 10):1441-1446. PubMed ID: 17005795
    [Abstract] [Full Text] [Related]

  • 15. The role of complement in the opsonization of mucoid and non-mucoid strains of Pseudomonas aeruginosa.
    Baltimore RS, Shedd DG.
    Pediatr Res; 1983 Dec 24; 17(12):952-8. PubMed ID: 6419197
    [Abstract] [Full Text] [Related]

  • 16. Nonspecific immunoglobulin synthesis and elevated IgG levels in rabbits immunized with mucoid exopolysaccharide from cystic fibrosis isolates of Pseudomonas aeruginosa.
    Pier GB, Elcock ME.
    J Immunol; 1984 Aug 24; 133(2):734-9. PubMed ID: 6234359
    [Abstract] [Full Text] [Related]

  • 17. Opsonization of mucoid and non-mucoid Pseudomonas aeruginosa by serum from patients with cystic fibrosis assessed by a chemiluminescence assay.
    LeBlanc CM, Bortolussi R, Issekutz AC, Gillespie T.
    Clin Invest Med; 1982 Aug 24; 5(2-3):125-8. PubMed ID: 6811181
    [Abstract] [Full Text] [Related]

  • 18. Anti-idiotype vaccines for immunity to bacterial polysaccharides: induction of functional antibodies to polysaccharide antigens of Pseudomonas aeruginosa.
    Schreiber JR.
    Springer Semin Immunopathol; 1993 Aug 24; 15(2-3):235-46. PubMed ID: 7504840
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Protection against mucoid Pseudomonas aeruginosa in rodent models of endobronchial infections.
    Pier GB, Small GJ, Warren HB.
    Science; 1990 Aug 03; 249(4968):537-40. PubMed ID: 2116663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.